1. 1) Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am. J. Med., 128, 461–470 (2015).
2. 2) Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann. Rheum. Dis., 77, 808–818 (2018).
3. 3) Robinson KP, Chan JJ. Colchicine in dermatology: a review. Australas. J. Dermatol., 59, 278–285 (2018).
4. 4) Putterman C, Ben-Chetrit E, Caraco Y, Levy M. Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin. Arthritis Rheum., 21, 143–155 (1991).
5. 5) Hung IF, Wu AK, Cheng VC, Tang BS, To KW, Yeung CK, Woo PC, Lau SK, Cheung BM, Yuen KY. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin. Infect. Dis., 41, 291–300 (2005).